The 2023 Translational Research Symposium hosted by the Translational Research Office (TRO) will take place on the 23rd March at the Saïd Business School, Oxford. This is an in-person event only and places are limited.

Full details of the Medical and Life Sciences Translational Fund (MLSTF) scheme will be presented and previous successful MLSTF projects will be showcased, demonstrating successful pathways to translation. This year’s event will also include talks covering key elements of the translational strategy that should be considered including: market size and opportunity, IP strategy and health economics. Panel discussions will also take place around regulatory strategies, establishing an impacting co-creation team, and how to write a winning translational grant application. Full agenda including the list of speakers and panel members will be made available soon.

Please register using the link provided.

Agenda

10:00 Registration and Refreshments
10:30 Welcome, Professor Matthew Wood, Deputy Head Division (Innovation)

10:40 Medical and Life Sciences Translational Fund 2023
Dr Deepak Kumar, Head of the Translational Research Office (TRO)

• Oxford Biomedica Innovation Fund | Dr Yatish Lad
• Novo Nordisk Innnovation Fund | Dr Bill Haynes
• CRUK co-funding opportunities | Dr Gillian Shuttleworth
• University Challenge Seed Fund | Dr Jane Liew
• EPSRC IAA | Dr Anuj Bhatt

11:20 Big Pharma & Oxford in the Immunology Space | Dr Gillian Tannahill (J&J Innovation)

11:30 Showcase of Successful MLSTF Awards | Dr Kavita Subramaniam (TRO)

• Novel Intravascular Ultrasound (IVUS) Drug Delivery Strategy for Peripheral Artery Restenosis| Associate Prof. James Kwan (Engineering Science, Oxford)
• New lamps for old: Developments in somatostatin analogues |Professor Rajesh Thakkar (NDM, Oxford)
• Utrophin modulators for Duchenne muscular dystrophy: from bench to clinic| Professor Angela J. Russel (Chemistry and Pharmacology, Oxford)

12:15 Lunch and Networking

13:30 Understanding the market size and opportunity of your technology | Dr Rupert Osborn (IP Pragmatics)
13:50 Never too early to consider your IP strategy? | Gemma Christie (Keltie LLP)

14:10 Effective regulatory strategies for medical technologies
Panel members: Dr Toni Day (Chair; OrganOx), Dr Peter Bowness (MCRA), Mr Daniel Voyce (OrganOx), Dr Tina Amina (Drug Device Combination & Medtech)

14:40 Afternoon Break

15:00 Health Economics: How to prove your innovation provides value for money?
Dr Ashley Aitken (Oxford AHSN)

15:20 Creating that A team who will help deliver your work plan
Panel members: Dr Nessa Carey (Chair), Dr Rachel Hemsley (Sygnature), Dr Nick Darvill (CGT Catapult), Dr Sally Makady (CGT Catapult), Dr Claire Brown (OSE)

15:50 The Winning Translational Grant Application: What the Reviewers are looking for?
Panel members: Dr Nessa Carey (Chair), Dr Agnes Leong (UKRI MRC), Prof. Fadi Issa (MRC DPFS Panellist), Dr Gillian Shuttleworth (CRUK)

16:20 Closing Remarks| Dr Deepak Kumar (TRO)